Therefore, while others have shown in preclinical experiments that CD146 expression is necessary for the induction of EMT, our data in primary breast tumors suggests that CD146 expression alone is insufficient to drive a breast cancer tumor cell into EMT. This evidence concerns the gene MCAM and breast neoplasm.